Elsevier provides free access to research and clinical resources via Mpox Information Center to accelerate fight against viral disease

For the benefit of healthcare professionals, researchers and the public in the fight against mpox, Elsevier, a global leader in scientific information and analytics, has today relaunched its Mpox Information Center.

In response to the World Health Organization (WHO) recently declaring mpox a public health emergency of international concern (PHEIC), Elsevier’s Mpox Information Center provides free access to all mpox-related information across Elsevier’s journals, medical books and clinical resources. It will be continuously updated with the latest research and clinical information on the viral disease and its treatment. Over 1,700 mpox-related research articles and book chapters published by Elsevier are now freely available on ScienceDirect, Elsevier’s world leading platform of peer-reviewed scholarly literature. The content will be machine-readable to enable researchers to use text and data mining technologies to identify patterns and relationships in the data.

Esra Erkal, EVP, Communications for Elsevier, said: “The Elsevier Mpox Information Center supports healthcare professionals, researchers, policy makers and the public by bringing together the latest knowledge related to mpox in one place so that best efforts can be made towards awareness, prevention and treatment. As we have done in previous public health emergencies, we will continually update the Information Center to help accelerate the fight against this devastating virus.”

The Mpox Information Center provides free access to content curated in consultation with Elsevier clinicians and other experts. It brings together content from the company’s scientific journals, medical books, monographs and clinical information solutions as well as resources from other information providers and major health and government organizations including WHO and the U.S. Centers for Disease Control and Prevention. Information typically used by practicing nurses and physicians, plus resources designed specifically for patients and their families, is also available.

These various resources will continue to be made available for as long as the mpox public health emergency is ongoing. Our response to mpox follows that of previous healthcare emergencies such as Ebola, SARS, Zika, MERS, and Coronavirus.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies to help impact makers achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @ElsevierConnect.